Suchergebnisse - "Igarashi, Ataru"

PubPharm (14)

1

Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine

enthalten in: Vaccine | 2024

von Kohli, M. | Maschio, M. | Lee, A. | +1

2

Predicting the Societal Value of Lecanemab in Early Alzheimer's Disease in Japan : A Patient-Level Simulation

enthalten in: Neurology and therapy | 2023

von Igarashi, A. | Azuma, M. | Zhang, Q. | +6

3

Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation

enthalten in: Neurology and Therapy | 2023

von Igarashi, A. | Azuma, M. | Zhang, Q. | +6

4

Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation

enthalten in: Neurology and Therapy | 2023

von Igarashi, A. | Azuma, M. | Zhang, Q. | +6

5

Cost-effectiveness of digital therapeutics for essential hypertension

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2022

von Nomura, A. | Tanigawa, T. | Kario, K. | +1

CommentIn: Hypertens Res. 2022 Oct;45(10):1549-1551. - PMID 35859024

6

Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2022

von Igarashi, A. | Maruyama-Sakurai, K. | Kubota, A. | +4

7

Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan

enthalten in: Diabetes therapy | 2022

von Igarashi, A. | Maruyama-Sakurai, K. | Kubota, A. | +4

8

Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan

enthalten in: Diabetes therapy | 2022

von Igarashi, A. | Maruyama-Sakurai, K. | Kubota, A. | +4

9

Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan

enthalten in: Diabetes therapy | 2022

von Igarashi, A. | Maruyama-Sakurai, K. | Kubota, A. | +4

10

Cost-Effectiveness Analysis of Percutaneous Patent Foramen Ovale Closure Preventing Secondary Ischemic Stroke in Japan

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2021

von Inoue, S. | Igarashi, A. | Iguchi, Y. | +1